According to recent animal studies, men with Omicron infections may respond better to the oral medication Molnupiravir than women
Research published in October 2021 in the BMJ showed that Molnupiravir reduced the risk of hospitalization by 50% in people at higher risk of severe COVID-19. While COVID-19 vaccines have been crucial in helping reduce the number of fatalities caused by SARS-CoV-2 infections, antivirals also played a part. One of those drugs is molnupiravir, which the Food & […]
